Skip to main
ALHC
ALHC logo

Alignment Healthcare (ALHC) Stock Forecast & Price Target

Alignment Healthcare (ALHC) Analyst Ratings

Based on 10 analyst ratings
Buy
Strong Buy 30%
Buy 40%
Hold 30%
Sell 0%
Strong Sell 0%

Bulls say

Alignment Healthcare Inc. is positioned to gain significantly from the anticipated stronger Medicare Advantage (MA) rate update in 2026, particularly as many managed care organizations are scaling back benefits while Alignment Healthcare retains a competitive Stars funding advantage. The company's integrated MA-VBC model is expected to facilitate long-term market share expansion and above-average growth through effective health outcomes. Additionally, gross profit per member per month (PMPM) for the initial cohorts is projected to range between $90-$150, increasing to over $230 PMPM by the latter years, suggesting a solid profitability trajectory as the company's membership scales.

Bears say

Alignment Healthcare's stock outlook is negatively influenced by challenges in realizing consistent results through its value-based care (VBC) model, which faces data friction across varying payors. Despite achieving lower Annualized Disenrollment Rate (ADK) during periods of heightened healthcare utilization, the complexities associated with its operational model and technology platform may detract from long-term financial stability. Additionally, although the company's valuation multiple is slightly above the long-term range for peer managed care organizations, persistent operational hurdles could hinder sustainable EBITDA growth and overall performance.

Alignment Healthcare (ALHC) has been analyzed by 10 analysts, with a consensus rating of Buy. 30% of analysts recommend a Strong Buy, 40% recommend Buy, 30% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Alignment Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Alignment Healthcare (ALHC) Forecast

Analysts have given Alignment Healthcare (ALHC) a Buy based on their latest research and market trends.

According to 10 analysts, Alignment Healthcare (ALHC) has a Buy consensus rating as of Nov 4, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $19.65, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $19.65, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Alignment Healthcare (ALHC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.